56 studies found for:    " September 09, 2009":" October 09, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" September 09, 2009":" October 09, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (56 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Study of Vitamin D Supplementation to Male HIV Sero-positive Patients
Condition: HIV Seropositive
Interventions: Drug: Rocaltrol;   Drug: Vitamin D;   Drug: Calcium
2 Unknown  Pilot Assessment of Lopinavir/Ritonavir and Maraviroc
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Drug: lopinavir/ritonavir plus maraviroc
3 Completed Europe-Africa Research Network for Evaluation of Second-line Therapy
Conditions: Human Immunodeficiency Virus;   HIV
Interventions: Drug: Aluvia + 2NRTIs;   Drug: Aluvia + raltegravir;   Drug: Aluvia monotherapy
4 Unknown  Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
5 Completed The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: Shang Ring circumcision
6 Completed Profile of HIV Seropositive Patients
Conditions: HIV Infection;   HIV Infections
Intervention:
7 Completed Genotype Based Personalized Prescription of Nevirapine
Conditions: Nevirapine Induced Rash;   Nevirapine Induced Hepatitis;   HIV;   Adverse Side Effects;   AIDS;   HIV Infections
Interventions: Genetic: Genetic test for NVP induced rash;   Other: 3TC/D4T/NVP or 3TC/AZT/NVP
8 Active, not recruiting Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Conditions: Immune Reconstitution Inflammatory Syndrome;   HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: Placebo
9 Active, not recruiting TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents
Conditions: HIV Infections;   HIV-1
Intervention: Drug: Etravirine
10 Completed Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
11 Completed Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
Conditions: HIV Prevention;   HIV Infections
Interventions: Drug: Tenofovir;   Drug: HEC Placebo;   Drug: Open label tenofovir tablet
12 Completed
Has Results
Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.
Condition: Acquired Immunodeficiency Syndrome
Intervention: Drug: lopinavir/ritonavir
13 Unknown  HIV-discordant Couple Intrauterine Insemination
Conditions: Infertility;   HIV Infections
Interventions: Other: Sperm washing and testing for HIV contamination;   Procedure: Intrauterine Insemination
14 Completed The St. Marys and The Mater Switch Study
Condition: HIV Infections
Intervention: Drug: Maraviroc
15 Active, not recruiting Using Heavy Water to Study Cell Dynamics in Parkinson's Disease
Conditions: Parkinson's Disease;   HIV Infections
Intervention:
16 Completed HIV Testing in the Emergency Department at Baystate Medical Center: A Pilot Program
Condition: HIV Infections
Intervention:
17 Completed HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children
Conditions: Malaria;   HIV Infections
Interventions: Drug: LPV/r + 2 NRTIs;   Drug: NVP or EFV + 2 NRTIs
18 Completed Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy
Condition: HIV Infections
Interventions: Biological: WT-gag-TCR modified T cells;   Biological: α/6-gag-TCR modified T cells;   Other: STI or Drug Holiday
19 Unknown  Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
Condition: HIV Infections
Intervention: Drug: maraviroc (Selzentry)
20 Completed
Has Results
Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
Condition: HIV Infection
Interventions: Biological: DNA + HIV-rAd5 vaccine;   Drug: ART intensification (raltegravir);   Drug: ART intensification (maraviroc)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years